Jan 4, 2021 4:05pm EST Virios Therapeutics to Present at the H.C. Wainwright Virtual BioConnect Conference
Dec 21, 2020 3:00pm EST Virios Therapeutics Announces Closing of Initial Public Offering and Full Exercise of Underwriter’s Over-Allotment Option
